A0A2R9B696 (A0A2R9B696_PANPA) Pan paniscus (Pygmy chimpanzee) (Bonobo)
Coagulation factor X UniProtKBInterProSTRINGInteractive Modelling
488 aa; Sequence (Fasta) ;
4 identical sequences: Homo sapiens: P00742, Q5JVE7; Pan troglodytes: H2Q7T9, A0A6D2WHH3
It is possible new templates exist for this target since these models were created.
Available Structures
158 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Cryo-em structure of human prothrombin:prothrombinase at 4.1 Angstrom resolution |
Heteromer P00734; P00742; P12259; | 100 | ||||
| Preliminary map of the Prothrombin-prothrombinase complex on nano discs |
Heteromer P00734; P00742; P12259; | 100 | 6×NAG; | |||
| Crystal Structure of Blood Coagulation Factor Xa in Complex with Ecotin M84R |
Heteromer P00742; P23827; | 100.0 | 8×MG; 2×NA; | |||
| Crystal structure of human FXA in complex with methyl (2Z)-3-[(3-chloro-1H-indol-7-yl)amino]-2-cyan… |
Heteromer P00742; | 100.0 | 4×GOL; 1×ENS; 1×CA; 1×NA; 1×MES; 1×ACT; | |||
| STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKI… |
Heteromer P00742; | 100 | ||||
| STRUCTURE OF HUMAN DES(1-45) FACTOR XA AT 2.2 ANGSTROMS RESOLUTION |
Heteromer P00742; | 100.0 | ||||
| X-ray crystal structure of human FXA in complex with 6-chloro-N-((3S)-2-oxo-1-(2-oxo-2-((5S)-8-oxo-… |
Heteromer P00742; | 100 | 1×FI1; 1×NA; 1×CA; 1×GOL; | |||
| FACTOR XA INHIBITOR COMPLEX |
Heteromer P00742; | 100 | 1×CA; 1×T87; | |||
| COAGULATION FACTOR XA INHIBITOR COMPLEX |
Heteromer P00742; | 99.15 | 1×CA; 1×DX9; | |||
| FACTOR XA INHIBITOR COMPLEX |
Heteromer P00742; | 100 | 1×CA; 1×R11; | |||
| Factor Xa inhibitor complex |
Heteromer P00742; | 100 | 1×894; 1×CA; 1×MG; | |||
| Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and… |
Heteromer P00742; | 100 | 1×C0Z; 1×CA; 1×MG; | |||
| Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and… |
Heteromer P00742; | 100 | 1×439; 1×CA; 1×MG; | |||
| The discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and b… |
Heteromer P00742; | 100 | 1×MZA; 1×CA; 1×MG; | |||
| Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with biaryl P4 motifs |
Heteromer P00742; | 100.0 | 1×GSV; | |||
| Crystal structure of factor Xa in complex with compound "1 |
Heteromer P00742; | 100 | 1×CA; 1×IIA; | |||
| Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and… |
Heteromer P00742; | 100 | 1×930; 1×CA; 1×MG; | |||
| factor Xa in complex with the dual thrombin-FXa inhibitor 58. |
Heteromer P00742; | 100 | 1×CA; 1×7R9; | |||
| Factor Xa in complex with the dual thrombin-FXa inhibitor 57. |
Heteromer P00742; | 100 | 1×CA; 1×6XS; | |||
| Structure of the C3bB proconvertase in complex with lufaxin and factor Xa |
Heteromer P00742; P00751; P01024; Q5WPU8; | 100 | 1×NAG; 1×MG; 2×NAG; | |||
| Factor Xa complex with GTC000101 |
Heteromer P00742; | 100.0 | 1×48U; | |||
| Structure and property based design of factor Xa inhibitors:biaryl pyrrolidin-2-ones incorporating … |
Heteromer P00742; | 100 | 1×CA; 1×MG; 1×GSI; | |||
| Selective and Dual Action Orally Active Inhibitors of Thrombin and Factor Xa |
Heteromer P00742; | 100.0 | 1×701; | |||
| Factor Xa complex with GTC000441 |
Heteromer P00742; | 100 | 1×CA; 1×44I; | |||
| Factor Xa complex with GTC000398 |
Heteromer P00742; | 100 | 1×CA; 1×48W; | |||
| factor Xa in complex with D46-5241 |
Heteromer P00742; | 100 | 2×CA; 1×D46; | |||
| Factor XA in complex with a cis-1,2-diaminocyclohexane derivative |
Heteromer P00742; | 100 | 2×CA; 1×D14; | |||
| CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX |
Heteromer P00742; | 100.0 | 1×GSJ; 1×CA; | |||
| Factor Xa complex with GTC000102 |
Heteromer P00742; | 100 | 1×CA; 1×MG; 1×4O5; | |||
| Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with monoaryl P4 mot… |
Heteromer P00742; | 100.0 | 1×461; | |||
| Selective and Dual Action Orally Active Inhibitors of Thrombin and Factor Xa |
Heteromer P00742; | 100 | 1×895; | |||
| Factor Xa complex with GTC000422 |
Heteromer P00742; | 100 | 1×CA; 1×MG; 1×987; | |||
| Factor Xa complex with GTC000401 |
Heteromer P00742; | 100.0 | 1×CA; 1×4O1; | |||
| CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR132747 |
Heteromer P00742; | 100 | 1×CA; 1×RRP; | |||
| Factor Xa complex with GTC000406 |
Heteromer P00742; | 100 | 1×CA; 1×MG; 1×4O6; | |||
| CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR200095 |
Heteromer P00742; | 100 | 1×CA; 1×RTR; | |||
| CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX |
Heteromer P00742; | 100 | 1×G15; 1×CA; | |||
| FACTOR XA IN COMPLEX WITH THE INHIBITOR (1S,2R,4S)-N1-[(5-chloroindol-2-yl)carbonyl]-4-(N,N-dimethy… |
Heteromer P00742; | 100 | 2×CA; 1×DT8; | |||
| CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208944 |
Heteromer P00742; | 100 | 1×CA; 1×RDR; | |||
| Factor Xa in complex with D102-4380 |
Heteromer P00742; | 100 | 2×CA; 1×D1Q; | |||
| Factor Xa in complex with the inhibitor 2-[[4-[(5-chloroindol-2-yl)sulfonyl]piperazin-1-yl] carbony… |
Heteromer P00742; | 100 | 2×CA; 1×D01; | |||
| Crystal structure of factor Xa in complex with 43 |
Heteromer P00742; | 100 | 1×IID; 1×CA; | |||
| FACTOR XA IN COMPLEX WITH THE INHIBITOR (-)-cis-N1-[(5-Chloroindol-2-yl)carbonyl]-N2-[(5-methyl-4,5… |
Heteromer P00742; | 100 | 2×CA; 1×D92; | |||
| FACTOR XA IN COMPLEX WITH THE INHIBITOR trans-N1-[(5-Chloroindol-2-yl)carbonyl]-N2-[(5-methyl-4,5,6… |
Heteromer P00742; | 100 | 2×CA; 1×D93; | |||
| Factor Xa in complex with the inhibitor 4-[(5-chloroindol-2-yl)sulfonyl]-2-(2-methylpropyl)-1-[[5-(… |
Heteromer P00742; | 100 | 2×CA; 1×D91; | |||
| Aminopyrrolidine Factor Xa inhibitor |
Heteromer P00742; | 99.57 | 1×H22; 1×CA; 1×NA; | |||
| Factor Xa in complex with a potent 2-amino-ethane sulfonamide inhibitor |
Heteromer P00742; | 100 | 1×CA; 1×A7I; | |||
| factor Xa in complex with the dual thrombin-FXa inhibitor 31. |
Heteromer P00742; | 100 | 1×CA; 1×VYR; | |||
| Human coagulation factor Xa in complex with M55159 |
Heteromer P00742; | 100 | 1×CA; 1×XME; | |||
| Human coagulation factor Xa in complex with M54471 |
Heteromer P00742; | 100 | 1×CA; 1×XMK; | |||
| Human coagulation factor Xa in complex with M55192 |
Heteromer P00742; | 100 | 1×CA; 1×XMC; | |||
| Human coagulation factor Xa in complex with M54476 |
Heteromer P00742; | 100 | 1×CA; 1×XMJ; | |||
| Crystal structure of factor Xa in complex with 50 |
Heteromer P00742; | 100 | 1×CA; 1×I1H; | |||
| Human coagulation factor Xa in complex with M55125 |
Heteromer P00742; | 100 | 1×CA; 1×XMG; | |||
| Human coagulation factor Xa in complex with M55590 |
Heteromer P00742; | 100 | 1×CA; 1×XMB; | |||
| Human coagulation factor Xa in complex with M55532 |
Heteromer P00742; | 100 | 1×CA; 1×XMA; | |||
| CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45 |
Heteromer P00742; | 100 | 1×CA; 1×IIE; | |||
| Human coagulation factor Xa in complex with M55124 |
Heteromer P00742; | 100 | 1×CA; 1×XMH; | |||
| Human coagulation factor Xa in complex with M55143 |
Heteromer P00742; | 100 | 1×CA; 1×XMF; | |||
| Crystal structure of factor Xa in complex with 21 |
Heteromer P00742; | 100 | 1×CA; 1×IIB; | |||
| Human coagulation factor Xa in complex with M55113 |
Heteromer P00742; | 100 | 1×CA; 1×XMI; | |||
| Human coagulation factor Xa in complex with M55165 |
Heteromer P00742; | 100 | 1×CA; 1×XMD; | |||
| Crystal Structure of the Antithrombin-S195A Factor Xa-Pentasaccharide Complex |
Heteromer P00742; P01008; | 100 | 1×NAG; 1×ZDO; 1×CA; 2×NAG; | |||
| Factor Xa - cation inhibitor complex |
Heteromer P00742; | 99.57 | 1×BI7; 1×CA; 1×NA; | |||
| FACTOR XA - CATION INHIBITOR COMPLEX |
Heteromer P00742; | 99.57 | 1×FJD; 2×NA; | |||
| FACTOR XA - CATION INHIBITOR COMPLEX |
Heteromer P00742; | 99.57 | 1×XWG; 2×NA; | |||
| FACTOR XA - CATION INHIBITOR COMPLEX |
Heteromer P00742; | 99.57 | 1×Y5H; 2×NA; | |||
| Factor XA in complex with the inhibitor (R)-6-(2'-((3- HYDROXYPYRROLIDIN-1-YL)METHYL)BIPHENYL-4-YL)… |
Heteromer P00742; | 100 | 1×FFG; | |||
| Factor XA in complex with the inhibitor N-(2-(((5-chloro-2-pyridinyl) amino)sulfonyl)phenyl)-4-(2-o… |
Heteromer P00742; | 100 | 1×FXA; | |||
| Aminopyrrolidine Factor Xa inhibitor |
Heteromer P00742; | 99.57 | 1×LZG; 1×CA; 3×NA; 2×CL; | |||
| Aminopyrrolidine Factor Xa inhibitor |
Heteromer P00742; | 99.57 | 1×H25; 1×CA; 2×NA; 2×CL; | |||
| Factor Xa - cation |
Heteromer P00742; | 99.55 | 1×784; 1×NA; | |||
| Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor |
Heteromer P00742; | 100 | 1×CA; 1×NA; 1×IVK; | |||
| Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and… |
Heteromer P00742; | 100 | 1×931; 1×CA; 1×MG; | |||
| Aminopyrrolidine-related triazole Factor Xa inhibitor |
Heteromer P00742; | 99.57 | 1×H21; 1×CA; 1×NA; | |||
| Factor XA in complex with the inhibitor 1-(3'-amino-1,2-benzisoxazol-5'-yl)-n-(4-(2'-((dimethylamin… |
Heteromer P00742; | 100 | 1×IK8; | |||
| Factor xa in complex with the inhibitor 3-chloro-N-((1R,2S)-2-(4-(2-oxopyridin-1(2H)-yl)benzamido)c… |
Heteromer P00742; | 100 | 1×ME4; | |||
| Factor Xa complex with GTC000006 |
Heteromer P00742; | 100 | 1×CA; 1×4O4; | |||
| Factor XA in complex with the inhibitor 1-[2-(aminomethyl)phenyl]-N-(3-fluoro-2'-sulfamoylbiphenyl-… |
Heteromer P00742; | 100 | 1×M37; 1×CA; | |||
| Factor xa in complex with the inhibitor 5-chloro-N-(2-(4-(2-oxopyridin-1(2H)-yl)benzamido)ethyl)thi… |
Heteromer P00742; | 100 | 1×ME1; | |||
| CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX |
Heteromer P00742; | 100.0 | 1×GSQ; | |||
| CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031) COMPLEXED WITH FACTOR XA |
Heteromer P00742; | 100 | 1×CA; 1×CL; 1×Z34; 6×GOL; | |||
| Aminopyrrolidine Factor Xa inhibitor |
Heteromer P00742; | 99.57 | 1×LZI; 1×NA; | |||
| Factor Xa in complex with a phenylenediamine derivative |
Heteromer P00742; | 100 | 2×CA; 1×D90; | |||
| CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX |
Heteromer P00742; | 100 | 1×GS6; 1×CA; | |||
| CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX |
Heteromer P00742; | 100 | 1×GSX; 1×CA; | |||
| Factor Xa in complex with BAY59-7939 |
Heteromer P00742; | 100 | 1×RIV; 2×CA; | |||
| Crystal structure of a Human Factor Xa inhibitor complex |
Heteromer P00742; | 100 | 1×CA; 1×GSK; | |||
| Crystal Structure of Human Coagulation Factor XA Complexed with FXV673 |
Heteromer P00742; | 100 | 1×CA; 1×FXV; | |||
| CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX |
Heteromer P00742; | 100 | 1×GS5; 1×CA; | |||
| Factor Xa in complex with the inhibitor 3-(6-(2'-((dimethylamino)methyl)-4-biphenylyl)-7-oxo-3-(tri… |
Heteromer P00742; | 100 | 1×4QC; | |||
| Factor XA in complex with the inhibitor 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2'-(methylsulfonyl)bi… |
Heteromer P00742; | 100 | 1×M35; 1×CA; | |||
| FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(4-methoxyphenyl)-6-(4-(1-(pyrrolidin-1-ylmethyl)cyclopro… |
Heteromer P00742; | 100 | 1×CA; 1×LG0; | |||
| Factor xa in complex with the inhibitor 5-chloro-N-((1R,2S)-2-(4-(2-oxopyridin-1(2H)-YL)benzamido) … |
Heteromer P00742; | 100 | 1×ME5; | |||
| Factor Xa in complex with the inhibitor 1-(3-amino-1,2-benzisoxazol-5-yl)-6-(2'-(((3r)-3-hydroxy-1-… |
Heteromer P00742; | 100 | 1×5QC; | |||
| Factor xa in complex with the inhibitor 6-(2'- (methylsulfonyl)biphenyl-4-yl)-1-(3-(5-oxo-4,5-dihyd… |
Heteromer P00742; | 100 | 1×LGK; 2×NA; | |||
| Factor xa in complex with the inhibitor n-(3-fluoro-2'- (methylsulfonyl)biphenyl-4-yl)-1-(3-(5-oxo-… |
Heteromer P00742; | 100 | 1×LGJ; 2×NA; | |||
| Factor Xa in Complex with the Inhibitor APIXABAN (BMS-562247) AKA 1-(4-METHOXYPHENYL)-7-OXO-6-(4-(2… |
Heteromer P00742; | 100 | 1×CA; 1×GG2; | |||
| Factor xa in complex with the inhibitor 3-methyl-1-(3-(5- oxo-4,5-dihydro-1h-1,2,4-triazol-3-yl)phe… |
Heteromer P00742; | 100 | 1×LGM; 2×NA; | |||
| Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with monoaryl P4 mot… |
Heteromer P00742; | 100.0 | 1×898; | |||
| Anti-FX Fab of mim8 in complex with human FXa |
Heteromer P00742; | 100 | 1×0GJ; 1×CA; | |||
| Factor xa in complex with the inhibitor 1-(3-(5-oxo-4,5- dihydro-1h-1,2,4-triazol-3-yl)phenyl)-6-(2… |
Heteromer P00742; | 100 | 1×LGL; 2×NA; | |||
| Crystal structure of the factor Xa/NAP5 complex |
Heteromer P00742; Q16940; | 100 | 1×NA; | |||
| Crystal structure of human factor XA complexed with 3-chloro-N-(4-chloro-2-{[(5-chloropyridin-2-yl)… |
Heteromer P00742; | 100 | 2×CA; 1×663; | |||
| Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor |
Heteromer P00742; | 99.57 | 1×XBV; 1×CA; 1×NA; | |||
| Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor |
Heteromer P00742; | 100 | 1×OYJ; 1×CA; 1×NA; | |||
| Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor |
Heteromer P00742; | 100 | 1×455; 1×CA; 1×NA; | |||
| Aminopyrrolidine Factor Xa inhibitor |
Heteromer P00742; | 99.57 | 1×LZH; 1×CL; 1×CA; 1×NA; | |||
| Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor |
Heteromer P00742; | 100 | 1×RR8; 1×CA; 1×NA; | |||
| The discovery of glycine and related amino acid-based factor xa inhibitors |
Heteromer P00742; | 100 | 1×CA; 1×FXI; | |||
| Crystal Structure of FXa in complex with 4,4-disubstituted pyrrolidine-1,2-dicarboxamide inhibitor 2 |
Heteromer P00742; | 100 | 1×CA; 1×L1C; | |||
| Crystal structure of human factor XA complexed with 3-Chloro-4-(2-methylamino-imidazol-1-ylmethyl)-… |
Heteromer P00742; | 100 | 1×CA; 1×CL; 1×993; | |||
| Aminopyrrolidine Factor Xa inhibitor |
Heteromer P00742; | 99.57 | 1×LZF; 1×CA; 1×NA; | |||
| Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor |
Heteromer P00742; | 100 | 1×63C; 1×CA; 1×NA; | |||
| Factor Xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor |
Heteromer P00742; | 100 | 1×8NC; 1×CA; 1×NA; | |||
| Crystal Structure of FXa in complex with 4,4-disubstituted pyrrolidine-1,2-dicarboxamide inhibitor 1 |
Heteromer P00742; | 100 | 1×L1D; 1×CA; | |||
| Crystal Structure of Human Coagulation Factor XA Complexed with RPR208707 |
Heteromer P00742; | 100 | 1×CA; 1×PR2; | |||
| CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815 |
Heteromer P00742; | 100 | 1×CA; 1×815; | |||
| Crystal Structure of 3-chloro-N-[4-chloro-2-[[(4-chlorophenyl)amino]carbonyl]phenyl]-4-[(4-methyl-1… |
Heteromer P00742; | 100 | 1×CA; 1×XLC; 3×GOL; | |||
| CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR209685 |
Heteromer P00742; | 100 | 1×CA; 1×RRR; | |||
| Crystal Structure of 3-chloro-N-[4-chloro-2-[[(5-chloro-2-pyridinyl)amino]carbonyl]-6-methoxyphenyl… |
Heteromer P00742; | 100 | 1×CA; 1×XLD; 3×GOL; | |||
| Human factor Xa in complex with synthetic inhibitor benzylsulfonyl-dSer(Benzyl)-Gly-4-amidinobenzyl… |
Heteromer P00742; | 100 | 2×CA; 1×6PK; | |||
| CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515 |
Heteromer P00742; | 100 | 1×CA; 1×RPR; | |||
| Factor Xa in complex with the inhibitor 1-[6-methyl-4,5,6,7-tetrahydrothiazolo(5,4-c)pyridin-2-yl] … |
Heteromer P00742; | 100 | 2×CA; 1×D76; | |||
| Factor XA in complex with (R)-2-(1-ADAMANTYLCARBAMOYLAMINO)-3-(3-CARBAMIDOYL-PHENYL)-N-PHENETHYL-PR… |
Heteromer P00742; | 100 | 2×CA; 1×RUP; | |||
| An Orally Efficacious Factor Xa Inhibitor |
Heteromer P00742; | 100 | 1×CA; 1×230; | |||
| X-ray Structure of FXa in complex with 7-fluoroindazole |
Heteromer P00742; | 100 | 1×JNJ; | |||
| Discovery of Tetrahydropyrimidin-2(1H)-one derivative TAK-442: A potent, selective and orally activ… |
Heteromer P00742; | 100 | 1×443; 4×EDO; 3×CA; | |||
| Factor XA inhibitor |
Heteromer P00742; | 100 | 2×CA; 1×237; | |||
| DesGla-XaS195A Bound to Aptamer 11F7t |
Heteromer P00742; | 99.57 | 1×NA; 1×CA; 2×MG; | |||
| DesGla-XaS195A Bound to Aptamer 11F7t and Rivaroxaban |
Heteromer P00742; | 99.57 | 1×RIV; 1×NA; 1×CA; 2×MG; | |||
| Crystal Structure of FXa/selectide/NAPC2 ternary complex |
Heteromer P00742; Q16938; | 100 | 6×PO4; 3×ACT; 1×NA; | |||
| Aspartyl/Asparaginyl beta-hydroxylase (AspH) H679A in complex with Mn, NOG and Factor X peptide fra… |
Heteromer P00742; Q12797; | 95.0 | 1×MN; 1×OGA; 3×GOL; | |||
| Aspartyl/Asparaginyl beta-hydroxylase (AspH) H679A in complex with Factor X peptide fragment (39mer… |
Heteromer P00742; Q12797; | 95.0 | 3×FMT; 2×GOL; | |||
| Aspartyl/Asparaginyl beta-hydroxylase (AspH) oxygenase and TPR domains in complex with manganese, 3… |
Heteromer P00742; Q12797; | 94.44 | 1×MN; 1×Q1Z; | |||
| Aspartyl/Asparaginyl beta-hydroxylase (AspH) oxygenase and TPR domains in complex with L-2-hydroxyg… |
Heteromer P00742; Q12797; | 94.44 | 1×MN; 1×S2G; | |||
| Aspartyl/Asparaginyl beta-hydroxylase (AspH) oxygenase and TPR domains in complex with manganese, 3… |
Heteromer P00742; Q12797; | 94.44 | 1×MN; 1×U4B; | |||
| Aspartyl/Asparaginyl beta-hydroxylase (AspH) oxygenase and TPR domains in complex with D-4-hydroxy-… |
Heteromer P00742; Q12797; | 94.44 | 1×MN; 1×IO9; | |||
| Aspartyl/Asparaginyl beta-hydroxylase (AspH) oxygenase and TPR domains in complex with manganese, 5… |
Heteromer P00742; Q12797; | 94.44 | 1×MN; 1×U4Q; | |||
| Aspartyl/Asparaginyl beta-hydroxylase (AspH) oxygenase and TPR domains in complex with manganese, 3… |
Heteromer P00742; Q12797; | 94.44 | 1×GOL; 1×MN; 1×QA8; | |||
| Aspartyl/Asparaginyl beta-hydroxylase (AspH) oxygenase and TPR domains in complex with (S)-4-hydrox… |
Heteromer P00742; Q12797; | 94.44 | 1×MN; 1×GOL; 1×IOW; | |||
| Aspartyl/Asparaginyl beta-hydroxylase (AspH) H725A in complex with Factor X peptide fragment (39mer… |
Heteromer P00742; Q12797; | 94.44 | 3×GOL; 1×PPI; | |||
| Aspartyl/Asparaginyl beta-hydroxylase (AspH) oxygenase and TPR domains in complex with D-2-hydroxyg… |
Heteromer P00742; Q12797; | 94.44 | 2×GOL; 1×MN; 1×2HG; | |||
| Aspartyl/Asparaginyl beta-hydroxylase (AspH)oxygenase and TPR domains in complex with manganese, N-… |
Heteromer P00742; Q12797; | 94.44 | 1×MN; 1×OGA; 1×ACT; | |||
| Aspartyl/Asparaginyl beta-hydroxylase (AspH)oxygenase and TPR domains in complex with manganese, N-… |
Heteromer P00742; Q12797; | 100 | 1×MN; 1×OGA; 1×ACT; | |||
| Aspartyl/Asparaginyl beta-hydroxylase (AspH) oxygenase and TPR domains in complex with manganese, N… |
Heteromer P00742; Q12797; | 94.44 | 1×MN; 1×BR; 1×GOL; 1×UQK; | |||
| Aspartyl/Asparaginyl beta-hydroxylase (AspH)oxygenase and TPR domains in complex with manganese, 2,… |
Heteromer P00742; Q12797; | 94.44 | 1×MN; 1×PD2; 1×BR; 1×GOL; | |||
| Aspartyl/Asparaginyl beta-hydroxylase (AspH) oxygenase and TPR domains in complex with manganese, 2… |
Heteromer P00742; Q12797; | 94.44 | 1×MN; 1×AKG; | |||
| Aspartyl/Asparaginyl beta-hydroxylase (AspH) oxygenase and TPR domains in complex with manganese, 4… |
Heteromer P00742; Q12797; | 94.44 | 1×MN; 1×Q1W; | |||
| Aspartyl/Asparaginyl beta-hydroxylase (AspH)oxygenase and TPR domains in complex with manganese, N-… |
Heteromer P00742; Q12797; | 100 | 1×MN; 1×OGA; | |||
| X-ray crystal structure of human fxa in complex with (S)-N-((2-METHYLBENZOFURAN-5-YLAMINO)(2-OXO-1-… | homo-2-mer | 100.0 | 5×GOL; 1×MBM; 1×CA; 1×NA; | |||
| Crystal structure of human FxA in complex with (S)-2-cyano-1-(2-methylbenzofuran-5-yl)-3-(2-oxo-1-(… | homo-2-mer | 100.0 | 3×GOL; 1×YET; 1×CA; 1×NA; 1×MES; 4×ACT; 1×DMS; | |||
| FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S)-(3'-AMIDINO-3-BIPHENYLYL)-5-(4-PYRIDYL… | homo-2-mer | 100 | 2×CA; 1×4PP; | |||
| FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S)-(3'-AMIDINO-3-BIPHENYLYL)-5-(4-PYRIDYL… | homo-2-mer | 100 | 1×CA; 1×4PP; | |||
| CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79. | monomer | 100 | ||||
| CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125. | monomer | 100 | ||||
| CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41. | monomer | 100 | ||||
| CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45. | monomer | 100 | ||||
4 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 9cth.1.C | monomer | 0.64 | 100.00 | |||
| 5edm.1.A | monomer | 0.55 | 37.30 | |||
| 4o03.1.A | monomer | 0.52 | 1×CA; | 36.68 | ||
| 5edk.1.A | monomer | 0.52 | 37.06 | |||